Startup profile · funding coverage
Helix
Population genomics and clinical-research platform spun out of Illumina — consumer DNA marketplace.
Stage
growth
Status
private
Coverage
full
Why Helix is interesting
Raised $435M+ to pair sequencing with app ecosystem; a16z on cap table per investment list.
Key facts
- Series E (2021): Kleiner Perkins among lead investors; DFJ Growth, Warburg Pincus, and Temasek also in syndicate — Tracxn / Caplight
- Spun out of Illumina; raised $435M+ to pair sequencing infrastructure with a consumer DNA app ecosystem
Investors in our directory
Funds linked from Helix's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech Biotech & Life Sciences
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
FAQs about Helix
Funding context and why this company shows up in venture coverage.
Helix sequences consumer DNA and operates a platform where third-party apps deliver health, wellness, and ancestry insights on top of its genomics infrastructure.
Andreessen Horowitz (see /fund/andreessen-horowitz) and Kleiner Perkins (/fund/kleiner-perkins) are among publicly listed investors.
Helix raised a Series E in 2021 with Kleiner Perkins among lead investors; total funding exceeds $435M across prior rounds.
Helix pairs clinical-grade sequencing with an app marketplace — a platform play in consumer genomics rather than a single-test DTC brand.
Helix remains private as of July 2026.
Last updated: 2026-07-24